Product Images Pirfenidone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Pirfenidone NDC 46708-480 by Alembic Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - pirfenidone figure1

Figure 1 - pirfenidone figure1

The text describes a chart or graph presenting data on the percentage of patients experiencing worsening or no decline in %FVC (forced vital capacity) over a 52-week period. The chart is divided into categories of %FVC decline, ranging from 10% to 90+%. Two groups, Pirfenidone and Placebo, are being compared, with the number of participants in each group (278 and 277, respectively) noted. The only available data point shown in the chart is the absolute change in %FVC from baseline to week 52, which is labeled as a 10% increase.*

Figure 2 - pirfenidone figure2

Figure 2 - pirfenidone figure2

Figure 3 - pirfenidone figure3

Figure 3 - pirfenidone figure3

This is a graph showing the percentage of patients who are alive over time for two groups, Pirfenidone (n=623) and Placebo (n=624). The hazard ratio (HR) with a 95% confidence interval (Cl) is also provided.*

500 tablets - pirfenidone mg 267

500 tablets - pirfenidone mg 267

500 tablets - pirfenidone mg 801

500 tablets - pirfenidone mg 801

pirfenidone - pirfenidone structure

pirfenidone - pirfenidone structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.